There is a critical mismatch between available organs for transplant and acutely or critically
ill patients with end-stage organ disease. Patients who may benefit from organ …

JUSTIFICATIVA E OBJETIVOS: O transplante de órgãos sólidos vem sendo considerado o
tratamento de eleição para várias doenças terminais que afetam rim, pâncreas, fígado …

The sources of donor organs for use in lung transplant (LTx) and the selection criteria used
have taken a quantum leap forward in the last few years. Novel sources of lungs are being …

Thyroid hormone has a wide range of cardiovascular effects which are mediated at both
genomic and non-genomic levels. As a stress response to surgery, the non-thyroidal illness …

There are still many controversial aspects regarding which method is best for managing
organ donors to prevent, lessen, or even reverse the organ alterations associated with brain …

Cardiac transplantation is the best treatment available for patients with end-stage
cardiomyopathy. Shortage of donor hearts is the main factor limiting the use of this treatment …

Steady improvements in islet cell processing technology and immunosuppressive protocols
have made pancreatic islet transplantation a clinical reality for the treatment of patients with …

Background: No consensus exists as to the maximal period of time allowable after brain
death (BD) before organ procurement rates begin to deteriorate. The aim of this study was to …

Introduction Brain death (BD) is known to compromise graft quality by causing
hemodynamic, metabolic, and hormonal changes. The abrupt reduction of female sex …

OBJECTIVES: The objective of this review was to depict the physiological and clinical
rationale for the use of vasopressin in hemodynamic support of organ donors. After …